Expression Génétique Microbienne, UMR8261 CNRS, Institut de Biologie Physico-Chimique, Université de Paris, Paris, France.
Molecular Epidemiology and Experimental Pathology (LR16IPT04), Institut Pasteur de Tunis/Université de Tunis el Manar, Tunis-Belvédère, Tunisia.
Methods Mol Biol. 2021;2209:35-52. doi: 10.1007/978-1-0716-0935-4_3.
RNA helicases are proteins found in all kingdoms of life, and they are associated with all processes involving RNA from transcription to decay. They use NTP binding and hydrolysis to unwind duplexes, to remodel RNA structures and protein-RNA complexes, and to facilitate the unidirectional metabolism of biological processes. Viral, bacterial, and eukaryotic parasites have an intimate need for RNA helicases in their reproduction. Moreover, various disorders, like cancers, are often associated with a perturbation of the host's helicase activity. Thus, RNA helicases provide a rich source of targets for the development of therapeutic or prophylactic drugs. In this review, we provide an overview of the different targeting strategies against helicases, the different types of compounds explored, the proposed inhibitory mechanisms of the compounds on the proteins, and the therapeutic potential of these compounds in the treatment of various disorders.
RNA 解旋酶是存在于所有生命领域的蛋白质,它们与从转录到降解的所有涉及 RNA 的过程都有关联。它们利用 NTP 结合和水解来解开双链体,重塑 RNA 结构和蛋白-RNA 复合物,并促进生物过程的单向代谢。病毒、细菌和真核寄生虫在其繁殖过程中都非常需要 RNA 解旋酶。此外,各种疾病,如癌症,通常与宿主解旋酶活性的紊乱有关。因此,RNA 解旋酶为开发治疗或预防药物提供了丰富的靶标。在这篇综述中,我们概述了针对解旋酶的不同靶向策略、所探索的不同类型的化合物、化合物对蛋白质的拟议抑制机制以及这些化合物在治疗各种疾病方面的治疗潜力。